The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744 · cited 1×
“Safety evaluations were based on routine adverse event onitoring, vital sign assessments, and a hypomania/mania ssessment based on 12 on the Young Mania Rating Scale YMRS) (Young et al 1978) or fulfilling DSM-IV criteria for a anic episode.”
MethodDevelopment of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
(1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
Papageorgis, D. (1991) · Behaviour Research and Therapy · doi:10.1016/0005-7967(91)90087-j · Cited by 1,534
Drevets, W. C. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00203-8 · Cited by 1,146
Mayberg, H. S., Brannan, S. K., Tekell, J. L., Silva, J. A., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01036-2 · Cited by 1,115 · cited 14×
“All patients enrolled in the study fulfilled SCID-P criteria for bipolar II depression and scored 20 of the MADRS at both the screening and baseline evaluations.”
MethodInfluentialTohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
(2001) · PubMed · Cited by 780
Manji, H. K., Quiroz, J. A., Sporn, J., Payne, J. L., Denicoff, K., A. Gray, N., Zarate, C. A., & Charney, D. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00117-3 · Cited by 505
Self-citationChen, G., Zeng, W., Yuan, P., Huang, L., Jiang, Y., Zhao, Z., & Manji, H. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.720879.x · Cited by 494
Self-citationLong-term symptomatic status of bipolar I vs. bipolar II disorders
Judd, L. L., Schettler, P. J., Akiskal, H. S., Maser, J., Coryell, W., Solomon, D., Endicott, J., & Keller, M. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003341 · Cited by 389 · cited 2×
“This, in part, may be due to the tendency of ome antidepressants to induce hypomania, mania, or rapid ycling in bipolar patients (reviewed in Keck et al 2003; Muzina nd Calabrese 2003; Yatham et al 2003).”
BackgroundGoldberg, J. F., Burdick, K. E., & Endick, C. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.564 · Cited by 372
Manji, H. K., Moore, G. J., & Chen, G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00979-3 · Cited by 352
Self-citationManji, H. K., MD, Duman, F. A. R. S., & PhD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4260 · Cited by 330
Self-citationKoslow, S. H. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790080081011 · Cited by 312
Lambert, G., Johansson, M., Ågren, H., & Friberg, P. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.787 · Cited by 303
The role of dopamine in the mechanism of action of antidepressant drugs
D'Aquila, P. S., Collu, M., Gessa, G. L., & Serra, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00566-5 · Cited by 289
Placidi, G. P. A., Oquendo, M. A., Malone, K. M., Huang, Y.-Y., Ellis, S. P., & Mann, J. J. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01170-2 · Cited by 288
Manji, H. K., Moore, G. J., & Chen, G. (2000) · PubMed · Cited by 272
Self-citationImpact of Bipolar Disorder on a U.S. Community Sample
Calabrese, J. R., Hirschfeld, R. M. A., Reed, M., Davies, M. A., Frye, M. A., Keck, P. E., Lewis, L., McElroy, S. L., McNulty, J. P., & Wagner, K. D. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0412 · Cited by 264
Occurrence and Clinical Correlates of Psychiatric Comorbidity in Patients With Psychotic Disorders
Cassano, G. B., Pini, S., Saettoni, M., Rucci, P., & Dell'Osso, L. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0204 · Cited by 233
The mesolimbic dopamine system as a target for rapid antidepressant action
Willner, P. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199707003-00002 · Cited by 208
Dopamine D2 receptors in depression measured with single photon emission computed tomography
D'haenen, H. A., & Bossuyt, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)91202-5 · Cited by 189
BIPOLAR II DISORDER AND SUICIDAL BEHAVIOR
Rihmer, Z., & Pestality, P. (1999) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70101-5 · Cited by 186
Clinical and psychometric correlates of dopamine D2 binding in depression
SHAH, P. J., OGILVIE, A. D., GOODWIN, G. M., & EBMEIER, K. P. (1997) · Psychological Medicine · doi:10.1017/s0033291797005382 · Cited by 170
Efficacy and Safety of Fluoxetine in Treating Bipolar II Major Depressive Episode
Amsterdam, J. D., Garcia-Espana, F., Fawcett, J., Quitkin, F. M., Reimherr, F. W., Rosenbaum, J. F., Schweizer, E., & Beasley, C. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199812000-00003 · Cited by 167
Pramipexole — a new dopamine agonist for the treatment of Parkinson's disease
Bennett, J. P., & Piercey, M. F. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00307-4 · Cited by 163
Piercey, M. F. (1998) · PubMed · Cited by 157
Sporn, J., Ghaemi, S. N., Sambur, M. R., Rankin, M. A., Recht, J., Sachs, G. S., Rosenbaum, J. F., & D, M. F. M. (2000) · Annals of Clinical Psychiatry · doi:10.1023/a:1009060800999 · Cited by 153
Peet, M., & Peters, S. (1995) · Drug Safety · doi:10.2165/00002018-199512020-00007 · Cited by 151
Pramipexole in treatment‐resistant depression: a 16‐week naturalistic study
Lattanzi, L., Dell’Osso, L., Cassano, P., Pini, S., Rucci, P., Houck, P. R., Gemignani, A., Battistini, G., Bassi, A., Abelli, M., et al. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01171.x · Cited by 150
BLACK, K. J., Hershey, T. G., Koller, J. M., Videen, T. O., Mintun, M. A., Price, J. L., & Perlmutter, J. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012260599 · Cited by 142
Klimke, A., Larisch, R., Janz, A., Vosberg, H., Müller-Gärtner, H. W., & Gaebel, W. (1999) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(99)00009-8 · Cited by 136
Ebert, D., Loew, T. H., Feistel, H., & Pirner, A. (1996) · Psychopharmacology · doi:10.1007/bf02246416 · Cited by 133
Efficacy and Safety of Venlafaxine in the Treatment of Bipolar II Major Depressive Episode
Amsterdam, J. D. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199810000-00010 · Cited by 116
Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia
Roy, A., Pickar, D., Linnoila, M., Doran, A. R., Ninan, P. T., & Paul, S. M. (1985) · Psychiatry Research · doi:10.1016/0165-1781(85)90065-4 · Cited by 113
CSF amine metabolites in depression
Reddy, P. L., Khanna, S., Subhash, M. N., Channabasavanna, S. M., & Rao, B. S. S. R. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90198-9 · Cited by 108
Adjunctive Dopamine Agonists in Treatment-Resistant Bipolar II Depression: an Open Case Series
Perugi, G., Toni, C., Ruffolo, G., Frare, F., & Akiskal, H. S. (2001) · Pharmacopsychiatry · doi:10.1055/s-2001-15872 · Cited by 108
Psychomotor disturbance in depression: defining the constructs
Parker, G. B., Hadži-Pavlović, D., Brodaty, H., Boyce, P. M., Mitchell, P. B., Wilhelm, K. A., Hickie, I. B., & Eyers, K. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90049-p · Cited by 105
Are Dopamine Receptor Agonists Neuroprotective in Parkinson??s Disease?
Le, W., & Jankovic, J. J. (2001) · Drugs & Aging · doi:10.2165/00002512-200118060-00001 · Cited by 100
Venlafaxine monotherapy in women with bipolar II and unipolar major depression
Amsterdam, J. D., & García‐España, F. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00149-4 · Cited by 96
Keck, P. E., McElroy, S. L., & Arnold, L. M. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70334-5 · Cited by 86
Dopamine in manic depressive illness
Silverstone, T. (1985) · Journal of Affective Disorders · doi:10.1016/0165-0327(85)90020-5 · Cited by 77
Neuroprotective effects of D3 dopamine receptor agonists
Carvey, P. M., McGuire, S. O., & Ling, Z. D. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00061-4 · Cited by 70
Antidepressant monotherapy for bipolar type II major depression
Amsterdam, J. D., & Brunswick, D. J. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00066.x · Cited by 63
Maj, J., & Rogóż, Z. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050151 · Cited by 59
Yatham, L. N., Calabrese, J. R., & Kusumakar, V. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00019.x · Cited by 59
Fluoxetine Treatment of Bipolar II Depression
Simpson, S. G., DePaulo, J. R., & Ciraulo, D. A. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199102000-00008 · Cited by 57
Arnt, J., Hyttel, J., & Overø, K. F. (1984) · PubMed · Cited by 52
Long-term studies of dopamine agonists
Hubble, J. P. (2002) · Neurology · doi:10.1212/wnl.58.suppl_1.s42 · Cited by 51
Advances in the pharmacologic treatment of bipolar depression
Keck, P. E., Nelson, E. B., & McElroy, S. L. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01741-9 · Cited by 49
Pergolide: an antidepressant adjuvant for mood disorders?
Bouckoms, A. J., & Mangini, L. (1993) · PubMed · Cited by 49
Pramipexole Augmentation of a Selective Serotonin Reuptake Inhibitor in the Treatment of Depression
DeBattista, C., Solvason, H. B., Breen, J. A. H., & Schatzberg, A. F. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00029 · Cited by 48
Pramipexole in Refractory Bipolar Depression
Goldberg, J. F., Frye, M. A., & Dunn, R. T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.798 · Cited by 46
OSTOW, M. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.2.320-a · Cited by 39
CSF monoamine metabolites, depression, and suicide.
Åsberg, M., Bertilsson, L., & Mårtensson, B. (1984) · PubMed · Cited by 38
Synergistic effect of pramipexole and sertraline in the forced swimming test.
Maj, J., & Rogóż, Z. (2000) · PubMed · Cited by 34
Nordin, C. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06411.x · Cited by 15
Recent placebo-controlled acute trials in bipolar depression: focus on methodology
Muzina, D. J., & Calabrese, J. R. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003559 · Cited by 13
Comparison of pramipexole, fluoxetine, and placebo in patients with major depression
(2000) · doi:10.1002/(sici)1520-6394(2000)11:2<58::aid-da2>3.0.co;2-h
Cited by
Drevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241
“Selective attention (without shifting set) and working memory (Landro et al. 2001; Rose and Ebmeier 2006; Stordal et al. 2004) have been found to be impaired in depression, but these findings have not been found consistently (Purcell et al. 1997), and the results are complicated further by the fact…”
BackgroundResultYatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244
Ashok, A. H., Marques, T. R., Jauhar, S., Nour, M. M., Goodwin, G. M., Young, A. H., & Howes, O. D. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.16 · Cited by 546
Metadata
- Authors
- Zarate, C. A., Payne, J. L., Singh, J., Quiroz, J. A., Luckenbaugh, D. A., Denicoff, K. D., Charney, D. S., & Manji, H. K.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2004-07
- Volume
- 56
- Issue
- 1
- Pages
- 54-60
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W2142544704
- Cited by
- 347
- References
- 61
- FWCI
- 15.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.